Source: International Congress 2016 – IPF treatment II
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hannah Toellner (Burntisland, United Kingdom), Hannah Toellner, W. Beswick, M.G. Crooks, C. Donaldson, I. Forrest, S.P. Hart, C. Leonard, M. Major, A.J. Simpson, N. Chaudhuri. Clinical experience with nintedanib for IPF in 3 UK tertiary referral centres. Eur Respir J 2016; 48: Suppl. 60, 4961

Member's Comments

No comment yet.

Related content which might interest you: Clinical profile of pulmonary hypertension at a tertiary care centre, India Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Variability in access and referral to pulmonary rehabilitation in European bronchiectasis patients enrolled in the EMBARC registry Source: International Congress 2018 – Latest advances in pulmonary rehabilitation assessment and content Year: 2018 Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry Source: Eur Respir J 2015; 46: 186-196 Year: 2015 IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 What proportion of patients with Idiopathic Pulmonary Fibrosis fall outside UK prescribing criteria for anti-fibrotic treatment? A UK specialist centre review. Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Selected clinical highlights from the 2012 ERS congress in Vienna Source: Eur Respir J 2013; 41: 1219-1227 Year: 2013 Clinical experience with Nintedanib for treatment of idiopathic pulmonary fibrosis (IPF) in Spain. Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Frequency of chronic pulmonary aspergillosis in patients treated for pulmonary tuberculosis at a tertiary care hospital in Karachi, Pakistan. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Pulmonary nocardiosis in renal transplant patients in a tertiary care hospital in Pakistan Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections Year: 2020 Management of idiopathic pulmonary fibrosis in France: A survey of 1,456 pulmonologists Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Safety and tolerability of immunosuppression in non-IPF ILD: clinical experience from a tertiary ILD centre. Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Pulmonary aspergillous; clinical features and outcomes in a tertiary care hospital Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Clinical findings at initial presentation of IPF patients at a university hospital referral center Source: International Congress 2014 – ILDs 5 Year: 2014 Differing clinical courses of IPF at an acute district general hospital Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Idiopathic pulmonary fibrosis and systemic sclerosis-interstitial lung disease: features at admission to a tertiary pulmonology unit. Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Acute exacerbation of ILD: an Indian tertiary centre experience Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early single centre Irish experience Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Do tertiary paediatric hospitals deal with the same spectrum of paediatric pulmonary hypertension as multicentre registries? Source: Eur Respir J 2013; 41: 236-239 Year: 2013